Real-time enrollment status for this hematopoietic and lymphatic system neoplasm clinical trial
Current Status
Suspended
Checked: July 13, 2026 at 2:07 PM UTC
| NCT Number | NCT07126301 |
| Recruiting Status | Suspended |
| Condition | Hematopoietic and Lymphatic System Neoplasm |
| Phase | Clinical Trial |
| Target Enrollment | 60 participants |
| Active Locations | 2 sites in the US |
| Sponsor | City of Hope Medical Center |
| Last Updated on CT.gov | July 13, 2026 (14 hours ago) |
As of July 13, 2026: Clinical trial NCT07126301 is currently suspended participants. This clinical trial study for hematopoietic and lymphatic system neoplasm is not currently accepting new participants at 2 locations across the United States. The study is sponsored by City of Hope Medical Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT07126301 is currently suspended. The study may resume recruiting in the future.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07126301 was last updated 14 hours ago (July 13, 2026). HelloStudys verifies this status automatically.